MRI在评估肝细胞癌分化程度中的研究进展  

Advance researches on MRI in evaluation of pathological differentiation for hepatocellular carcinoma

作　　者：成东亮 黄伟康 文戈[2] 刘健萍[1] 高明勇[1] CHENG Dongliang;HUANG Weikang;WEN Ge;LIU Jianping;GAO Mingyong(Department of Radiology, the First People's Hospital of Foshan, Foshan 528000, China;Medical Imaging Center, Nanfang Hospital Zengcheng branch of Southern Medical University, Guangzhou 511300, China)

机构地区：[1]佛山市第一人民医院影像科,佛山528000 [2]南方医科大学南方医院增城院区影像中心,广州511300

出　　处：《磁共振成像》2019年第9期703-706,共4页Chinese Journal of Magnetic Resonance Imaging

摘　　要：肝癌的病理学分级是肿瘤预后独立的预测因素,低分化肝细胞肝癌(hepatocellular carcinoma,HCC)术后复发率高、预后差,因此客观的评价肿瘤的病理分级对于治疗方案的选择、预后评估有重要的意义。该文对MRI在肝癌病理分级评估中的研究进展进行综述。Pathological grade of hepatocellular carcinoma (HCC) is an independent predictor of tumor prognosis. Poorly differentiated HCC has a high recurrence rate and poor prognosis. So accurate grading of HCC is closely related to clinical decision and prognosis prediction. In this paper, MR in the evaluation of preoperative pathological grade of HCC was reviewed.

关 键 词：癌 肝细胞 病理学 磁共振成像 

分 类 号：R445.2[医药卫生—影像医学与核医学] R735.7[医药卫生—诊断学]